# Bliss GVS Pharma Limited – FDA Inspection, Mar 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/bliss-gvs-pharma-limited/0082de5f-2af1-42ea-9dae-9670116c49b2
Source feed: FDA_Inspections

> FDA inspection 1202164 of Bliss GVS Pharma Limited, March 17, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202164
- Company Name: Bliss GVS Pharma Limited
- Inspection Date: 2023-03-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)

Company: https://www.keypedia.com/companies/bliss-gvs-pharma-limited/7ec8d057-d16a-43cd-9c4b-89c9b0614c31

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c